U.S. flag

An official website of the United States government

NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 28, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003324083.2

Allele description [Variation Report for NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)]

NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)

Gene:
BTD:biotinidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.1
Genomic location:
Preferred name:
NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)
HGVS:
  • NC_000003.12:g.15645208G>A
  • NG_008019.2:g.48857G>A
  • NG_008019.3:g.48858G>A
  • NM_000060.4:c.1352G>A
  • NM_001281723.4:c.1292G>A
  • NM_001281724.3:c.1292G>A
  • NM_001281725.3:c.1292G>A
  • NM_001323582.2:c.1292G>A
  • NM_001370658.1:c.1292G>AMANE SELECT
  • NM_001370752.1:c.1015+277G>A
  • NM_001370753.1:c.399+3151G>A
  • NM_001407364.1:c.1292G>A
  • NM_001407365.1:c.1292G>A
  • NM_001407366.1:c.1292G>A
  • NM_001407367.1:c.1292G>A
  • NM_001407368.1:c.1292G>A
  • NM_001407369.1:c.1292G>A
  • NM_001407370.1:c.1292G>A
  • NM_001407371.1:c.1292G>A
  • NM_001407372.1:c.1292G>A
  • NM_001407373.1:c.1292G>A
  • NM_001407374.1:c.1292G>A
  • NM_001407375.1:c.1292G>A
  • NM_001407376.1:c.1292G>A
  • NM_001407377.1:c.1292G>A
  • NM_001407378.1:c.1292G>A
  • NP_000051.1:p.Gly451Asp
  • NP_001268652.2:p.Gly431Asp
  • NP_001268652.2:p.Gly431Asp
  • NP_001268653.2:p.Gly431Asp
  • NP_001268654.1:p.Gly431Asp
  • NP_001268654.1:p.Gly431Asp
  • NP_001310511.1:p.Gly431Asp
  • NP_001310511.1:p.Gly431Asp
  • NP_001357587.1:p.Gly431Asp
  • NP_001394293.1:p.Gly431Asp
  • NP_001394294.1:p.Gly431Asp
  • NP_001394295.1:p.Gly431Asp
  • NP_001394296.1:p.Gly431Asp
  • NP_001394297.1:p.Gly431Asp
  • NP_001394298.1:p.Gly431Asp
  • NP_001394299.1:p.Gly431Asp
  • NP_001394300.1:p.Gly431Asp
  • NP_001394301.1:p.Gly431Asp
  • NP_001394302.1:p.Gly431Asp
  • NP_001394303.1:p.Gly431Asp
  • NP_001394304.1:p.Gly431Asp
  • NP_001394305.1:p.Gly431Asp
  • NP_001394306.1:p.Gly431Asp
  • NP_001394307.1:p.Gly431Asp
  • NC_000003.11:g.15686715G>A
  • NM_001281723.3:c.1292G>A
  • NM_001281725.2:c.1292G>A
  • NM_001323582.1:c.1292G>A
  • P43251:p.Gly451Asp
Protein change:
G431D
Links:
UniProtKB: P43251#VAR_005118; dbSNP: rs397514419
NCBI 1000 Genomes Browser:
rs397514419
Molecular consequence:
  • NM_001370752.1:c.1015+277G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001370753.1:c.399+3151G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000060.4:c.1352G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281723.4:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281724.3:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281725.3:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001323582.2:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370658.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407364.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407365.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407366.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407367.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407368.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407369.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407370.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407371.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407372.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407373.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407374.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407375.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407376.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407377.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407378.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004029300Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jul 28, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene.

Swango KL, Demirkol M, Hüner G, Pronicka E, Sykut-Cegielska J, Schulze A, Mayatepek E, Wolf B.

Hum Genet. 1998 May;102(5):571-5. Erratum in: Hum Genet 1998 Jun;102(6):712.

PubMed [citation]
PMID:
9654207

Biotinidase deficiency: Spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007-2014).

Gannavarapu S, Prasad C, DiRaimo J, Napier M, Goobie S, Potter M, Chakraborty P, Karaceper M, Munoz T, Schulze A, MacKenzie J, Li L, Geraghty MT, Al-Dirbashi OY, Rupar CA.

Mol Genet Metab. 2015 Nov;116(3):146-51. doi: 10.1016/j.ymgme.2015.08.010. Epub 2015 Aug 31.

PubMed [citation]
PMID:
26361991
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004029300.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: BTD c.1292G>A (p.Gly431Asp) results in a non-conservative amino acid change located in the C-terminal domain (IPR043957) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251428 control chromosomes (i.e., 2 heterozygotes; gnomAD v2.1 Exomes dataset). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1292G>A has been reported in the literature in individuals affected with Biotinidase Deficiency (e.g., Swango_1998, Lindau-Shepard_2012, Gannavarapu_2015). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26361991, 27625817, 9654207). One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024